Herpes Zoster (Shingles) Market Forecast (2022-2027)
Herpes Zoster (Shingles) Market Size is estimated to reach $275.9 million by 2027 and is poised to grow at a CAGR of 3.5% over the forecast period of 2022-2027. The varicella-zoster virus, which is a common viral infection of the nerves, causes herpes zoster (HZ), also known as shingles. People over 50 years of age and those with weakened immune systems are more likely to develop shingles. According to National Center for Biotechnology Information (NCBI) in March 2021, a cumulative incidence of HZ ranges from 2.9–19.5 cases per 1,000 population and an incidence rate of HZ ranges from 5.23–10.9 cases per 1,000 person-years. Incidence rates (6.05–12.8 versus 4.30–8.5 cases per 1,000 person-years) were higher in females than males. Such growing HZ cases and postherpetic neuralgia and the need for Post Herpetic Neuralgia Treatment and Shingles Vaccine are driving the Herpes Zoster (Shingles) Industry growth. Download Report Sa...